Anti-inflammatory prevents pancreatic cancer in mice

An inflammation-fighting drug limits premalignant lesions in mice prone to getting pancreatic cancer. The new finding suggests that this drug or related ones might prevent pancreatic cancer in people who face an elevated risk of developing it. Risk factors include smoking or having a relative with the disease.

Pancreatic-cancer cells often harbor a mutation in a gene called Kras.